Dr. M. Devane (Greenville, SC, USA)
EXPANDING HCC MANAGEMENT PROCEDURES
SeQure® 1.9 Fr clinical cases
Dr. M. Devane (Greenville, SC, USA)
EXPANDING SUPERSELECTIVE HCC EMBOLIZATION
Superselective HCC embolization using 1.9 Fr SeQure® reflux control microcatheter
Meet the Expert : Prof. Christof Matthias Sommer (Heidelberg University Hospital, DE) "Transpedal and Transnodal Lymphangiography (TL) in diagnostic set-up".
Francisco C. Carnevale (Sao Paulo, Brazil)
Performing the perfected technique for Prostate Artery Embolization (PAE) using SeQure® microcatheters
Geert Maleux (Leuven, Belgium)
SeQure® microcatheters could help to make embolization more secure
Jafar Golzarian (Minneapolis, USA)
CIRSE 2019 - Microspheres embolization and flow dynamic: what do we know?
Geert Maleux (Leuven, Belgium)
CIRSE 2019 - Reduced non-target embolization (NTE) & Better delivery with SeQure® innovative microcatheters
Florian Wolf (Vienna, Austria)
CIRSE 2019 - Clinical applications of SeQure® control reflux microcatheters
Irene Bargellini (Pisa, Italy)
New microcatheters could help reduce the “everyday challenge” of non-target embolization
Thierry de Baere (Villejuif, France)
ET 2019 - Non-target embolization (NTE): from concept to clinical situation
Tim Bryant (Southampton, United Kingdom)
ET 2019 - Prostate artery embolisation (PAE): Securing our practice
Learn more on our products in clinical practice
P20000256